Robert BristowMD, PhD, FRCPC
Professor

Contact Info

T. (416) 946-2936
F. (416) 946-4442

Location

Princess Margaret Cancer Centre
610 University Avenue
Toronto
ON, M5G 2M9

Accepting

Please contact Faculty Member for more information

Degree/Qualifications

MSc, University of Toronto
PhD, University of Toronto
MD, University of Toronto
FRCPC, Radiation Oncology

Professional Memberships

Associate Member, Institute of Medical Sciences, University of Toronto

Appointments

Professor, Department of Radiation Oncology, University of Toronto
Professor, Department of Medical Biophysics, University of Toronto
Radiation Oncologist, Princess Margaret Hospital/University Health Network
Clinician-Scientist, Ontario Cancer Institute, Princess Margaret Hospital

Research/Teaching

Research Synopsis:

  • Spatio-Temporal Targeting and Amplification of Radiation Response program (STTARR)
  • Medical biophysics
     

Publications and Awards

Recent Publications

Ishkanian AS , Mallof CS, Ho J, Meng A, Albert M, Syed A, van der Kwast T, Milosevic M, Yoshimoto M, Squire JA, Lam W and Bristow RG. High-Resolution Array CGH Identifies Novel Regions of Genomic Alteration in Intermediate-Risk Prostate Cancer. Prostate, 69(10): 1091-100, 2009. (IMPACT FACTOR 4.1)

Ali M, Kim H, Cleary S, Gallinger S, Cupples, C, Bristow R: Characterization of mutant MUTYH proteins associated with familial colorectal cancer, Gastroenterology, 135(2):499-507, August 2008. (IMPACT FACTOR 14)

Bristow R and Hill RP. Hypoxia, DNA-dsb Repair and Genetic Instability. Nature Reviews Cancer, 8(3): 180-192, 2008.

Chan N, Koritzinsky M, Zhao H, Bindra R, Glazer PM, Powell S, Belmaaza A, Wouters B, Bristow R. Chronic hypoxia decreases synthesis of homologous recombination prteins to offset chemoresistance and radioresistance. Cancer Research, 68(2):605-14, 2008.

Al Rashid ST, Dellaire G, Cuddihy A, Jalali F, Vaid M, Coackley C, Folkard M, Xu Y, Chen B, Chen D, Lilge L, Prise K, Bazett-Jones D and Bristow R. Evidence for the Direct Binding of Phosphorylated p53 to Sites of DNA Break In Vivo”. Cancer Research, 65(23):10810-10821, 2005.

Back to Top